2018 annual financial data
Addex Therapeutics 2018 Operating margin
Direct answer
Operating margin was -23.57%.
Operating income was -1,424,625 CHF and net income was -1,644,798 CHF.
Operating cash flow was 1,751,729 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,043,855 CHF
- Operating income
- -1,424,625 CHF
- Net income
- -1,644,798 CHF
- Operating cash flow
- 1,751,729 CHF